Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic retinopathy: can we modify its course?

L I Rand1

  • 1Beetham Eye Institute, Joslin Diabetes Center, Boston, Massachusetts.

The American Journal of Medicine
|February 21, 1991
PubMed
Summary

Developing new therapies for diabetic retinopathy requires a deeper understanding of the disease. This study presents a disease model to guide the conceptualization of novel interventions beyond current treatments like panretinal laser photocoagulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anterior clinoid mucocele masquerading as retrobulbar neuritis.

Ophthalmic plastic and reconstructive surgery·1996
Same author

Cardiovascular autonomic neuropathy and proliferative diabetic retinopathy.

American journal of ophthalmology·1995
Same author

Psychosocial adjustment to advanced proliferative diabetic retinopathy.

Diabetes care·1993
Same author

Different determinants of neovascularization on the optic disc and on the retina in patients with severe nonproliferative diabetic retinopathy.

Archives of ophthalmology (Chicago, Ill. : 1960)·1993
Same author

Risk for cardiovascular autonomic neuropathy is associated with the HLA-DR3/4 phenotype in type I diabetes mellitus.

Annals of internal medicine·1992
Same author

Risk of early-onset proliferative retinopathy in IDDM is closely related to cardiovascular autonomic neuropathy.

Diabetes·1992

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Medical Research

Background:

  • Diabetic retinopathy is a leading cause of vision loss.
  • Current treatments, such as panretinal laser photocoagulation, do not modify the disease's progression.
  • Understanding the disease process is crucial for developing effective therapies.

Purpose of the Study:

  • To present a conceptual model of diabetic retinopathy progression.
  • To identify critical stages for potential therapeutic intervention.
  • To guide the development of novel treatments for diabetic retinopathy.

Main Methods:

  • Conceptual framework development.
  • Literature review on diabetic retinopathy pathogenesis.
  • Disease process modeling.

Main Results:

  • A framework for understanding diabetic retinopathy is proposed.
  • Key stages in disease development are highlighted.
  • Potential targets for interventional therapy are conceptualized.

Conclusions:

  • A comprehensive disease model is essential for advancing diabetic retinopathy treatment.
  • Novel therapeutic strategies can be developed by targeting critical disease stages.
  • Further research into disease mechanisms will facilitate the creation of vision-preserving therapies.

Related Experiment Videos